Actively Recruiting
Mindfulness Effects on Cognition and Brain Function in Early-Stage Alzheimer's Disease A Randomized Study Comparing Mindfulness Training to Waitlist Control
Led by VA Boston Healthcare System · Updated on 2025-01-27
100
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating whether mindfulness meditation can improve thinking, memory, brain function, daily function, and quality of life in older adults with and without cognitive impairment, including those with mild cognitive impairment, early-stage Alzheimer's disease, traumatic brain injury, aging, or healthy elderly status. The study seeks to understand how mindfulness affects cognition and brain health compared to no intervention. Participants are divided into two groups for this purpose. One group will participate in a 10-week virtual mindfulness class based on Mindfulness-based Stress Reduction (MBSR). This class includes mindfulness training with focused attention, group discussions, mindful movement, and daily home practice using mindfulness recordings. The other group will be on a waitlist for 10 weeks before they begin the same mindfulness course. Outcomes will be measured at baseline, after 10 weeks, and at 2, 4, and 6 months. Participants will complete cognitive tests, surveys, computerized tasks, and brain imaging assessments including EEG and MRI before and after the intervention. Researchers will evaluate changes in neuropsychological test performance, computerized task results, brain activity and structure, and survey responses over 10 weeks. This comprehensive monitoring aims to measure the effects of mindfulness on cognition and brain health in older adults over the course of the study.
CONDITIONS
Official Title
Mindfulness for Cognition in Early-stage Alzheimer's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy older adults with cognitive performance within 1.0 standard deviation for age and education norms on neuropsychological tests
- Mild cognitive impairment participants with delayed recall or other cognitive domain scores worse than 1.5 standard deviations for age and education norms
- Mini-Mental State Examination (MMSE) score between 25 and 30
- Montreal Cognitive Assessment (MoCA) score between 20 and 30
You will not qualify if you...
- No access to a computer, smartphone, or internet
- Unable to understand informed consent or have moderate dementia
- Mood disorders (e.g., PTSD, depression, anxiety) or alcohol and drug use interfering with daily life or requiring hospitalization within past 5 years
- Cerebrovascular disease
- Medical conditions severely impairing cognition such as stroke, frontotemporal dementia, or Parkinson's disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
VA Boston Healthcare System - Jamaica Plain Campus
Boston, Massachusetts, United States, 02130
Actively Recruiting
Research Team
K
Katherine W Turk, MD
K
Kathy Y Xie, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here